Effects of acute exposure to aluminum on cognition in humans

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 70, Issue 23, 2007, Pages 2011-2019

  Molloy, D W ^a   Standish, T I ^a   Nieboer, E ^b,c   Turnbull, J D ^b   Smith, S D ^b   Dubois, S ^d  

^a St Peter's Hospital   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF TROMSØ   (Norway)

^d ST JOSEPH'S CARE GROUP   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; APOLIPOPROTEIN E4; PLACEBO;

ADULT; AGED; ALUMINUM BLOOD LEVEL; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NEUROPSYCHOLOGY; PRIORITY JOURNAL; RANDOMIZATION; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALUMINUM; ALUMINUM HYDROXIDE; ALZHEIMER DISEASE; ANTACIDS; APOLIPOPROTEIN E4; COGNITION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTESTINAL ABSORPTION; MALE; MIDDLE AGED;

EID: 35648993561     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287390701551142     Document Type: Article

References (26)

1. Benton, A. L., Hamsher, K. deS., Barney, N. R., and Spreen, O. 1983. Serial digit learning in contributions to neuropsychological assessment. New York: Oxford University Press.
2. Bertram, L., and Tanzi, R. E. 2004. The current status of Alzheimer's disease genetics: What do we tell the patients? Pharmacol. Res. 50:385-396.
3. Bertram, L., and Tanzi, R. E. 2005. The genetic epidemiology of neurodegenerative disease. J. Clin. Invest. 115:1449-1457.
4. Betard, C., Robitaille, Y., Gee, M., Tiberghien, D., Larrivee, D., Roy, P., Mortimer, J. A., and Gauvreau, D. 1994. Apo E allele frequencies in Alzheimer's disease, Lewy body dementia, Alzheimer's disease with cerebrovascular disease and vascular dementia. NeuroReport 5:1893-1896.
5. Day, J. P. 1990. Biochemistry of aluminum in relation to the assessment of aluminum exposure in humans. Environ. Geochem. Health 12:75-76.
6. Estes, W. K. 1974. Learning theory and intelligence. Am. Psychol. 29:740-749.
7. Exley, C., and Esiri, M. M. 2006. Severe cerebral congophilic angiopathy coincident with increased brain aluminum in a resident of Camelford. Cornwall, U.K. J. Neurol. Neurosurg. Psychiat. 77:877-879.
8. Feldman, R. G. 1999. Occupational and environmental neurotoxicology, pp. 129-145. Philadelphia: Lippincott-Raven.
9. Hewitt, C. D., Winborne, K., Margrey, D., Nicholson, J. R. P., Savory, M. G., Savory, J., and Wills, M. R. 1990. Critical appraisal of two methods for determining aluminum in blood samples. Clin. Chem. 36:1466-1469.
10. Krewski, D., Yokel, R. A., Nieboer, E., Borchelt, D., Cohen, J., Harry, J., Kacew, S., Lindsay, J., Mahfouz, A. M., and Rondeau, V. 2007. Human health risk assessment for aluminum, aluminum oxide, and aluminum hydroxide. J. Toxicol. Environ. Health B, in press.
11. Lewis, R., and Kupke, T. 1997. The Lafayette Clinic repeatable neuropsychological test battery: Its development and research applications. Paper presented at the annual meeting of the Southeastern Psychological Association, Hollywood, FL.
12. Lönnerdal, B., and Sandström, B. 1995. Factors influencing the uptake of metal ions from the digestive tract. In Bioinorganic medicine, vol. I, ed. G. Berthon, pp. 331-337. New York: Marcel Dekker.
13. McMillan, T. M., Freemont, A. J., Herxheimer, A., Denton, J., Taylor, A. P., Pazianas, M., Cummin, A. R. C., and Eastwood, J. B. 1993. Camelford water poisoning accident: Serial neuropsychological assessments and further observations on bone aluminum. Hum. Exp. Toxicol. 12:37-42.
14. Nieboer, E., Gibson, B. L., Oxman, A. D., and Kramer, J. R. 1995. Health effects of aluminum: A critical review with emphasis on aluminum in drinking water. Environ. Rev. 3:29-81.
15. Reitan, R. M. 1955. The relationship of the Trail Making Test to organic brain damage. J. Consult. Psychol. 19:393-395.
16. Rowland, A., Grainger, R., Stanwell Smith, R., Hicks, N., and Hughes, A. 1990. Water contamination in North Cornwall: A retrospective cohort study into acute and short-term effects of the aluminum sulphate incident in July 1988. J. R. Soc. Health 5:166-172.
17. Savory, J., Brown, S., Bertholf, R. L., Mendoza, N., and Wills, M. R. 1988. Aluminum. Methods Enzymol. 158:289-301.
18. Schlatter, C., Steinegger, A., Rickenbacher, U., Hans, C., and Lengyel, A. 1990. Aluminum levels in the blood plasma of persons working in the aluminum industry. Environ. Geochem. Health. 12:59-64.
19. Swartz, R. D. 1985. Deferroxamine and aluminum removal. Am. J. Kidney Dis. 6:358-364.
20. Taylor, E. M. 1959. The appraisal of children with cerebral deficits. Cambridge, MA: Harvard University Press.
21. Taylor, G. A., Ferrier, I. N., McLoughlin, I. J., Fairbairn, A. F., McKeith, I. G., and Edwardson, J. A. 1992. Gastrointestinal absorption of aluminum in Alzheimer's disease: Response to aluminum citrate. Age Ageing 21:81-90.
22. Weberg, R., and Berstad, A. 1986. Gastrointestinal absorption of aluminum from single doses of aluminum containing antacids in man. Eur. J. Clin. Invest. 16:428-432.
23. Wechsler, D. 1955. Wechsler Adult Intelligence Scale. Manual. New York: Psychological Corporation.
24. Yokel, R. A. 1994. Aluminum chelation: chemistry, clinical, and experimental studies and the search for alternatives to desferrioxamine. J. Toxicol. Environ. Health 41:131-174.
25. Yokel, R. A., Allen, D. D., and Ackley, D. C. 1999. The distribution of aluminum into and out of the brain. J. Inorg. Biochem. 76:127-132.
26. Zannis, V. I., Dardaissis, D., and Zannis, E. E. 1993. Genetic mutations affecting human lipotproteins, their receptors, and their enzymes. Adv. Human Genet. 21:145-319.